Principal Investigator
Emily Jonczak
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20231142
Clinical Trial Summary
ADI-PEG 20 or Placebo Plus Gemcitabine and Docetaxel in Previously Treated Subjects with Leiomyosarcoma (ARGSARC): A Randomized, Double-Blind, Multi-Center Phase 3 Trial
Phase
Phase III
Funding Agency/Sponsor
Industrial
Disease
Bone and Soft Tissue Cancers
Contact Information
Phone Number
305-243-2647